查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2040571

消費者健康契約製造市場規模、佔有率和趨勢分析報告：按產品、服務、最終用途、地區和細分市場分類的預測（2026-2033 年）

Consumer Health Contract Manufacturing Market Size, Share & Trends Analysis Report By Product, By Service, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

消費者健康領域契約製造市場概述

2025年全球消費者健康契約製造市場規模估計為1,382億美元，預計到2033年將達到2,788億美元。

預計從 2026 年到 2033 年，該市場將以 9.2% 的複合年成長率成長。這一市場成長被認為是由於消費者趨勢向預防醫學和健康生活方式的轉變所致。

為了提高成本效益、避免巨額資本投資並增強擴充性，企業擴大將生產營運外包。此外，D2C（直接面對消費者）模式和新興健康品牌的蓬勃發展也擴大了契約製造的基本客群。同時，大型製藥和營養保健品公司的策略性外包也有助於將管理資源集中在核心業務。

市場成長的驅動力在於對高效製造流程、嚴格法規要求以及專業技術的需求不斷成長。企業為避免建造和維護自有生產基礎設施所需的大量資本支出，紛紛選擇將生產活動外包，這一趨勢導致消費保健產業對契約製造的需求日益成長。

此外，對高效且經濟的生產流程日益成長的需求也是推動市場發展的重要因素。隨著企業努力提高營運效率並盡可能減少資本投入，許多企業開始轉向契約製造服務來滿足其生產需求。營養補充品、非處方藥和個人保健產品等消費保健品越來越受到消費者的青睞，導致對專用生產設施的需求不斷成長。此外，包括自動化和永續性在內的技術進步也對市場成長產生了積極影響。而且，嚴格的法令遵循也促使消費保健品和藥品品牌與契約製造合作，以滿足不斷變化的市場標準。

此外，配方研發方面的創新和技術進步也在推動市場成長方面發揮著至關重要的作用。先進技術、自動化、創新包裝和永續生產實踐是該行業的最新趨勢。技術進步和創新不僅使製造商能夠開發高效且永續的生產方法，還能開發出滿足消費者不斷變化的偏好和偏好的創新包裝。此外，電子商務和直接面對消費者（DTC）行銷管道的日益普及預計將增加對靈活高效生產流程的需求。這些因素預計將在未來幾年推動市場成長。

目錄

第1章 研究方法和範圍

第2章執行摘要

第3章：消費保健領域的契約製造市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 科技情勢
  • 定價模式分析
  • 關稅影響分析
  • 價值鏈分析
  • 市場分析工具

第4章：消費保健品產業的契約製造市場：產品特定估算與趨勢分析

  • 消費保健品產業契約製造市場：基於產品的波動分析
  • 消費保健品契約製造市場：按產品分類的估算和預測，2021-2033 年
  • 非處方藥
  • 營養補充品
  • 個人保健產品
  • 醫療器材
  • 其他

第5章：消費者健康領域的契約製造市場：按服務類型分類的估算與趨勢分析

  • 消費保健產業契約製造市場：基於服務的波動分析
  • 消費者健康領域契約製造市場：按服務分類的估算和預測，2021-2033 年
  • API生產
  • 製藥生產
  • 醫療設備製造
  • 包裝和標籤
  • 其他

第6章：消費保健領域的契約製造市場：依最終用途分類的估算與趨勢分析

  • 消費保健品產業的契約製造市場：依最終用途分析波動情況
  • 消費保健品契約製造市場：按最終用途分類的估算和預測，2021-2033 年
  • 製藥和生物製藥公司
  • 營養保健品公司
  • 藥用化妝品公司
  • 醫療設備製造商
  • 其他

第7章：消費保健品產業的契約製造市場：區域估算與趨勢分析

  • 區域市場概覽
  • 2025年及2033年區域市佔率分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特
    • 阿曼
    • 卡達

第8章 競爭情勢

  • 主要公司分類
    • Market Leaders
    • Emerging Players
  • 2025年市場估值分析（熱圖分析）
  • 公司簡介
    • Lonza
    • Recipharm AB
    • Piramal Consumer Products
    • Scapa Healthcare
    • Catalent, Inc.
    • SCN BestCo
    • Aenova Group
    • Ventiz Healthcare
    • Bionova
    • Aurohealth
    • Siegrified AG
    • Thermo Fisher Scientific Inc
    • Famar
    • Sirio Pharma Co., Ltd.
    • Tishcon Corporation
    • Vit-Best Nutrition Inc.
Product Code: GVR-4-68040-531-6

Consumer Health Contract Manufacturing Market Summary

The global consumer health contract manufacturing market size was estimated at USD 138.2 billion in 2025 and is projected to reach USD 278.8 billion by 2033, growing at a CAGR of 9.2% from 2026 to 2033. The market growth can be attributed to the shifting trends toward preventive health and wellness-oriented consumption patterns.

Companies are increasingly outsourcing manufacturing to achieve cost-efficiency and avoid high capital investment while improving scalability. In addition, the proliferation of D2C and emerging wellness brands is expanding the client base for contract manufacturers. Furthermore, strategic outsourcing by large pharmaceutical and nutraceutical companies is enhancing operational focus on core competencies.

The market growth is fueled by an increase in the demand for efficient manufacturing processes, compliance with strict regulations, and specialized expertise. The trend among companies to outsource manufacturing activities to avoid the substantial capital commitments associated with establishing and maintaining in-house production infrastructure has led increase in demand for contract manufacturing in the consumer health industry.

Further, the growing necessity for efficient and cost-effective production processes propels the market. As companies seek to improve operational efficiency while minimizing capital expenditure, many organizations have opted for contract manufacturing services for their production needs. Consumer health segments such as dietary supplements, over-the-counter drugs, and personal care products have gained popularity among consumers, resulting in demand for dedicated manufacturing facilities. In addition, advancements in technology that include automation and sustainability also contribute positively to market growth. Besides, stringent compliance regulations encourage consumer health and pharmaceutical brands to collaborate with contract manufacturing firms to meet the evolving standards of the market.

In addition, innovation and technological advancements in formulation development play a significant role in driving the market growth. Advanced technologies, automation, innovative packaging, and sustainable manufacturing practices are some of the latest trends within this industry. Technological advancements and innovations have led manufacturers to develop efficient and sustainable production practices, as well as innovative packaging to accommodate consumers' changing tastes and preferences. Further, the growing adoption of e-commerce and direct-to-consumer marketing channels is expected to drive the need for flexible and efficient production processes. Such factors are expected to drive the market growth in the upcoming years.

Global Consumer Health Contract Manufacturing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global consumer health contract manufacturing market based on product, service, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Over-the-counter (OTC) Drugs
  • Nutritional Supplements
  • Personal Care Products
  • Medical Devices
  • Others
  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • API Manufacturing
  • Finished Dose Manufacturing
  • Medical Device Manufacturing
  • Packaging & Labelling
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biopharmaceutical Companies
  • Nutraceutical Companies
  • Cosmeceutical Companies
  • Medical Device Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Service
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Bottom-Up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Consumer Health Contract Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Accelerating Shift Toward Preventive Health and Wellness-Oriented Consumption
      • 3.2.1.2. Cost-Efficiency and Capital Avoidance Driving Outsourcing Preference Among Brand Owners
      • 3.2.1.3. Proliferation of D2C and Emerging Wellness Brands Creating a Broader Client Base
      • 3.2.1.4. Strategic Outsourcing by Large Pharmaceutical and Nutraceutical Companies to Optimize Core Competencies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Intensifying Regulatory Complexity and Compliance Burden Across Multi-Format Manufacturing Operations
      • 3.2.2.2. Escalating Manufacturing Complexity and Capital Intensity Driven by Diversifying Consumer Format Preferences
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Tariff Impact Analysis
  • 3.6. Value Chain Analysis
    • 3.6.1. Supply Trends
    • 3.6.2. Demand Trends
  • 3.7. Market Analysis Tools
    • 3.7.1. Porter's Five Force Analysis
    • 3.7.2. PESTEL by SWOT Analysis

Chapter 4. Consumer Health Contract Manufacturing Market: Product Estimates & Trend Analysis

  • 4.1. Consumer Health Contract Manufacturing Market, By Product: Segment Dashboard
  • 4.2. Consumer Health Contract Manufacturing Market, By Product: Movement Analysis
  • 4.3. Consumer Health Contract Manufacturing Market Estimates & Forecasts, By Product, 2021 - 2033 (USD Million)
  • 4.4. Over-the-counter (OTC) Drugs
    • 4.4.1. Over-the-counter (OTC) Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Nutritional Supplements
    • 4.5.1. Nutritional Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Personal Care Products
    • 4.6.1. Personal Care Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Medical Devices
    • 4.7.1. Medical Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Consumer Health Contract Manufacturing Market: Service Estimates & Trend Analysis

  • 5.1. Consumer Health Contract Manufacturing Market, By Service: Segment Dashboard
  • 5.2. Consumer Health Contract Manufacturing Market, By Service: Movement Analysis
  • 5.3. Consumer Health Contract Manufacturing Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
  • 5.4. API Manufacturing
    • 5.4.1. API Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Finished Dose Manufacturing
    • 5.5.1. Finished Dose Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Medical Device Manufacturing
    • 5.6.1. Medical Device Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Packaging & Labelling
    • 5.7.1. Packaging & Labelling Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Consumer Health Contract Manufacturing Market: End Use Estimates & Trend Analysis

  • 6.1. Consumer Health Contract Manufacturing Market, By End Use: Segment Dashboard
  • 6.2. Consumer Health Contract Manufacturing Market, By End Use: Movement Analysis
  • 6.3. Consumer Health Contract Manufacturing Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
  • 6.4. Pharmaceutical & Biopharmaceutical Companies
    • 6.4.1. Pharmaceutical & Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Nutraceutical Companies
    • 6.5.1. Nutraceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Cosmeceutical Companies
    • 6.6.1. Cosmeceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Medical Device Companies
    • 6.7.1. Medical Device Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Consumer Health Contract Manufacturing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2025 & 2033
  • 7.3. North America
    • 7.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Australia
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.6. Oman
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.7. Qatar
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Key Participant Categorization
    • 8.1.1. Market Leaders
    • 8.1.2. Emerging Players
  • 8.2. Market Assessment Analysis, 2025 (Heat Map Analysis)
  • 8.3. Company Profiles
    • 8.3.1. Lonza
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Recipharm AB
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Piramal Consumer Products
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Scapa Healthcare
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Catalent, Inc.
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. SCN BestCo
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Aenova Group
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Ventiz Healthcare
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Bionova
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Aurohealth
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. Siegrified AG
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Service Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. Thermo Fisher Scientific Inc
      • 8.3.12.1. Company Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Service Benchmarking
      • 8.3.12.4. Strategic Initiatives
    • 8.3.13. Famar
      • 8.3.13.1. Company Overview
      • 8.3.13.2. Financial Performance
      • 8.3.13.3. Service Benchmarking
      • 8.3.13.4. Strategic Initiatives
    • 8.3.14. Sirio Pharma Co., Ltd.
      • 8.3.14.1. Company Overview
      • 8.3.14.2. Financial Performance
      • 8.3.14.3. Service Benchmarking
      • 8.3.14.4. Strategic Initiatives
    • 8.3.15. Tishcon Corporation
      • 8.3.15.1. Company Overview
      • 8.3.15.2. Financial Performance
      • 8.3.15.3. Service Benchmarking
      • 8.3.15.4. Strategic Initiatives
    • 8.3.16. Vit-Best Nutrition Inc.
      • 8.3.16.1. Company Overview
      • 8.3.16.2. Financial Performance
      • 8.3.16.3. Service Benchmarking
      • 8.3.16.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 4 Global Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 5 Global Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 6 North America Consumer Health Contract Manufacturing Market, by Country, 2021 - 2033 (USD Million)
  • Table 7 North America Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 8 North America Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 9 North America Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 10 U.S. Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 11 U.S. Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 12 U.S. Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 13 Canada Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 14 Canada Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 15 Canada Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 16 Mexico Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 17 Mexico Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 18 Mexico Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 19 Europe Consumer Health Contract Manufacturing Market, by Country, 2021 - 2033 (USD Million)
  • Table 20 Europe Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 21 Europe Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 22 Europe Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 23 UK Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 24 UK Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 25 UK Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 26 France Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 27 Germany Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 28 Germany Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 29 Germany Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 30 France Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 31 France Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 32 Italy Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 33 Italy Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 34 Italy Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 35 Spain Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 36 Spain Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 37 Spain Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 38 Denmark Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 39 Denmark Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 40 Denmark Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 41 Sweden Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 42 Sweden Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 43 Sweden Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 44 Norway Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 45 Norway Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 46 Norway Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Consumer Health Contract Manufacturing Market, by Country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 51 Japan Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 52 Japan Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 53 Japan Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 54 China Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 55 China Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 56 China Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 57 India Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 58 India Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 59 India Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 60 Thailand Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 61 Thailand Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 62 Thailand Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 63 South Korea Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 64 South Korea Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 65 South Korea Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 66 Australia Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 67 Australia Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 68 Australia Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 69 Latin America Consumer Health Contract Manufacturing Market, by Country, 2021 - 2033 (USD Million)
  • Table 70 Latin America Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 71 Latin America Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 72 Latin America Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 73 Brazil Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 74 Brazil Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 75 Brazil Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 76 Argentina Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 77 Argentina Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 78 Argentina Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 79 Middle East & Africa Consumer Health Contract Manufacturing Market, by Country, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 83 South Africa Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 84 South Africa Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 85 South Africa Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 89 UAE Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 90 UAE Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 91 UAE Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Consumer Health Contract Manufacturing Market, by Product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Consumer Health Contract Manufacturing Market, by Service, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Consumer Health Contract Manufacturing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 95 Oman Consumer Health Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 96 Oman Consumer Health Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 97 Oman Consumer Health Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 98 Qatar Consumer Health Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 99 Qatar Consumer Health Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 100 Qatar Consumer Health Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Commodity Flow Analysis
  • Fig. 7 Value-Chain-Based Sizing & Forecasting
  • Fig. 8 QFD Model Sizing & Forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market Snapshot
  • Fig. 11 Segment Snapshot 1
  • Fig. 12 Segment Snapshot 2
  • Fig. 13 Competitive Landscape Snapshot
  • Fig. 14 Parent market outlook, 2025 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2025 (USD Billion)
  • Fig. 16 Consumer Health Contract Manufacturing Market Dynamics
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 PESTEL Analysis
  • Fig. 19 Consumer Health Contract Manufacturing Market: Product outlook and key takeaways
  • Fig. 20 Consumer Health Contract Manufacturing Market: Product movement analysis
  • Fig. 21 Over-the-counter (OTC) Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Nutritional Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Personal Care Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Medical Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Consumer Health Contract Manufacturing Market: Manufacturing outlook and key takeaways
  • Fig. 27 Consumer Health Contract Manufacturing Market: Manufacturing movement analysis
  • Fig. 28 API Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Finished Dose Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Medical Device Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Packaging & Labelling Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Consumer Health Contract Manufacturing Market: End Use outlook and key takeaways
  • Fig. 34 Consumer Health Contract Manufacturing Market: End Use movement analysis
  • Fig. 35 Pharmaceutical & Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Nutraceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Cosmeceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Medical Device Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Regional Marketplace: Key Takeaways
  • Fig. 41 North America Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Key Country Dynamics
  • Fig. 43 U.S. Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Key Country Dynamics
  • Fig. 45 Canada Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Key Country Dynamics
  • Fig. 47 Mexico Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Europe Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key Country Dynamics
  • Fig. 50 UK Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key Country Dynamics
  • Fig. 52 Germany Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key Country Dynamics
  • Fig. 54 France Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key Country Dynamics
  • Fig. 56 Italy Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key Country Dynamics
  • Fig. 58 Spain Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key Country Dynamics
  • Fig. 60 Denmark Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key Country Dynamics
  • Fig. 62 Sweden Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key Country Dynamics
  • Fig. 64 Norway Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Asia Pacific Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key Country Dynamics
  • Fig. 67 Japan Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key Country Dynamics
  • Fig. 69 China Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key Country Dynamics
  • Fig. 71 India Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key Country Dynamics
  • Fig. 73 Thailand Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key Country Dynamics
  • Fig. 75 South Korea Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key Country Dynamics
  • Fig. 77 Australia Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Latin America Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key Country Dynamics
  • Fig. 80 Brazil Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key Country Dynamics
  • Fig. 82 Argentina Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 MEA Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key Country Dynamics
  • Fig. 85 South Africa Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Fig. Key Country Dynamics
  • Fig. 87 Saudi Arabia Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key Country Dynamics
  • Fig. 89 UAE Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key Country Dynamics
  • Fig. 91 Kuwait Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key Country Dynamics
  • Fig. 93 Oman Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key Country Dynamics
  • Fig. 95 Qatar Consumer Health Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)